Personalis, Inc. (PSNL)
14.48
-0.24
(-1.60%)
USD |
NASDAQ |
Nov 20, 10:21
Personalis Free Cash Flow : -107.69M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -107.69M |
| June 30, 2026 | -100.98M |
| March 31, 2026 | -84.65M |
| December 31, 2025 | -79.45M |
| September 30, 2025 | -66.17M |
| June 30, 2025 | -49.18M |
| March 31, 2025 | -46.71M |
| December 31, 2024 | -46.75M |
| September 30, 2024 | -54.65M |
| June 30, 2024 | -65.76M |
| March 31, 2024 | -68.16M |
| December 31, 2023 | -67.17M |
| September 30, 2023 | -76.53M |
| June 30, 2023 | -95.16M |
| March 31, 2023 | -119.66M |
| December 31, 2022 | -120.13M |
| Date | Value |
|---|---|
| September 30, 2022 | -112.68M |
| June 30, 2022 | -97.34M |
| March 31, 2022 | -89.72M |
| December 31, 2021 | -81.91M |
| September 30, 2021 | -66.43M |
| June 30, 2021 | -63.26M |
| March 31, 2021 | -49.36M |
| December 31, 2020 | -45.90M |
| September 30, 2020 | -42.04M |
| June 30, 2020 | -37.67M |
| March 31, 2020 | -34.28M |
| December 31, 2019 | -26.45M |
| September 30, 2019 | -24.41M |
| June 30, 2019 | -13.48M |
| March 31, 2019 | -2.588M |
| December 31, 2018 | -2.28M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Tempus AI, Inc. | -151.98M |
| 10X Genomics, Inc. | 93.77M |
| Alamar Biosciences, Inc. (California) | -67.04M |
| Champions Oncology, Inc. | -6.137M |
| Medpace Holdings, Inc. | 667.63M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.07M |
| Cash from Investing (Quarterly) | 24.01M |
| Cash from Financing (Quarterly) | 7.369M |
| Free Cash Flow Per Share (Quarterly) | -0.2812 |
| Free Cash Flow to Equity (Quarterly) | -29.35M |
| Free Cash Flow to Firm (Quarterly) | -30.11M |
| Free Cash Flow Yield | -6.86% |